title: Culture and immunological detection of Tropheryma whippelii from the duodenum of a patient with Whipple disease.
abstract: BACKGROUND
  Culture of Tropheryma whippelii has been established only once, in human fibroblast cell lines from a heart valve inoculum. Molecular-based diagnostic techniques, although highly sensitive, may be less specific. New diagnostic tools involving isolation of bacteria from contaminated intestinal biopsies and immunohistological detection need to be developed.
  
  
  OBJECTIVE
  To describe a novel method for detection and culture of T whippelii strains.
  
  
  METHODS
  Laboratory analysis of duodenal biopsy specimens from a patient with typical relapsing Whipple disease with intestinal involvement, performed Marseille, France, in March 2000. Biopsy specimens were decontaminated with antimicrobial agents and inoculated onto cell cultures. Mouse anti-T whippelii polyclonal antibodies were used to detect T whippelii in fixed specimens taken from the patient before and after relapse, compared with specimens from 10 controls. The genotype of the isolate was determined by amplification and sequencing of 2 DNA fragments (ITS and 23S rRNA).
  
  
  METHODS
  Isolation and genotyping of a new strain(s) of T whippelii from the case patient's biopsy specimens.
  
  
  RESULTS
  A strain was grown from the case patient's intestinal specimen that has a genotype different from the first strain isolated. During 2 episodes of Whipple disease, T whippelii bacteria were detected by immunochemistry in the patient's duodenal biopsy specimens, but not in controls.
  
  
  CONCLUSIONS
  A second strain of T whippelii has been isolated and a protocol for isolation from the intestine has been proven to be efficient. Immunodetection of T whippelii in intestinal biopsy specimens may provide a useful tool for the diagnosis and follow-up of patients with Whipple disease. Both techniques need further evaluation and confirmation.
authors.affiliation: Unité des Rickettsies, Faculté de Médecine, Université des la Méditerranée/CNRS, 27 Boulevard Jean Moulin, UPRESA 6020, 13385 Marseille CEDEX 05, France. Didier.Raoult@medecine.unive-mrs.fr
authors.forename: D
authors.initials: D
authors.lastname: Raoult
authors.forename: B
authors.initials: B
authors.lastname: La Scola
authors.forename: P
authors.initials: P
authors.lastname: Lecocq
authors.forename: H
authors.initials: H
authors.lastname: Lepidi
authors.forename: P E
authors.initials: PE
authors.lastname: Fournier
mesh_terms: D039903:Actinobacteria / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D000193:Actinomycetales Infections / Q000175:diagnosis* / Q000473:pathology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000032:analysis; D001706:Biopsy; D004269:DNA, Bacterial / Q000032:analysis; D004378:Duodenal Diseases / Q000382:microbiology* / Q000473:pathology; D005260:Female; D005838:Genotype; D006801:Humans; D007150:Immunohistochemistry; D018613:Microscopy, Confocal; D008856:Microscopy, Fluorescence; D016133:Polymerase Chain Reaction; D012336:RNA, Ribosomal, 16S; D012008:Recurrence; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D008061:Whipple Disease / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology
chemical_list: D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D012336:RNA, Ribosomal, 16S; D015662:Trimethoprim, Sulfamethoxazole Drug Combination